Clinical Trials · NCT02543255
Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University Health Network, Toronto
- Enrollment
- 76
- Start date
- Sep 2016
- Locations
- 5 sites, Canada
- Primary endpoint
- Pathological complete response